This past week was the Children's Oncology Group Fall meeting. Normally, the COG meets twice a year to discuss design and results (when available) of the latest clinical trials. This was a particularly special meeting, in that founding COG Chair, Dr. Gregory Reaman, was recognized for his phenomenal legacy of work with COG & CureSearch, and physician-scientist Dr. Peter Adamson took the leadership position moving forward. This meeting was well attended by pediatric oncology medical caregivers and the public alike. Our lab's contributions were a rhabdomyosarcoma presentation to the Soft Tissue Sarcoma Biology Special Session, as well as chairing (with the help of Maryam Fouladi) the CNS new therapeutics session. [ above right: Charles and Ross Vick, advisory director member of QuadW, discussing sarcoma research ]
No comments:
Post a Comment